383 related articles for article (PubMed ID: 18057241)
1. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.
Cameron JE; Yin Q; Fewell C; Lacey M; McBride J; Wang X; Lin Z; Schaefer BC; Flemington EK
J Virol; 2008 Feb; 82(4):1946-58. PubMed ID: 18057241
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
[TBL] [Abstract][Full Text] [Related]
6. Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.
Goormachtigh G; Ouk TS; Mougel A; Tranchand-Bunel D; Masy E; Le Clorennec C; Feuillard J; Bornkamm GW; Auriault C; Manet E; Fafeur V; Adriaenssens E; Coll J
J Virol; 2006 Aug; 80(15):7382-93. PubMed ID: 16840319
[TBL] [Abstract][Full Text] [Related]
7. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
[TBL] [Abstract][Full Text] [Related]
8. LMP1-miR-146a-CXCR4 axis regulates cell proliferation, apoptosis and metastasis.
Wang W; Zhang Y; Liu W; Xiao H; Zhang Q; Wang J; Luo B
Virus Res; 2019 Sep; 270():197654. PubMed ID: 31299195
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
10. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines.
Rahadiani N; Takakuwa T; Tresnasari K; Morii E; Aozasa K
Biochem Biophys Res Commun; 2008 Dec; 377(2):579-583. PubMed ID: 18926796
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.
Yu H; Lu J; Zuo L; Yan Q; Yu Z; Li X; Huang J; Zhao L; Tang H; Luo Z; Liao Q; Zeng Z; Zhang J; Li G
J Virol; 2012 Mar; 86(6):3088-99. PubMed ID: 22205737
[TBL] [Abstract][Full Text] [Related]
12. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
[TBL] [Abstract][Full Text] [Related]
14. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
[TBL] [Abstract][Full Text] [Related]
15. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
16. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
[TBL] [Abstract][Full Text] [Related]
17. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus growth/latency III program alters cellular microRNA expression.
Cameron JE; Fewell C; Yin Q; McBride J; Wang X; Lin Z; Flemington EK
Virology; 2008 Dec; 382(2):257-66. PubMed ID: 18950829
[TBL] [Abstract][Full Text] [Related]
19. The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.
Wang L; Howell MEA; Sparks-Wallace A; Zhao J; Hensley CR; Nicksic CA; Horne SR; Mohr KB; Moorman JP; Yao ZQ; Ning S
mBio; 2021 Oct; 12(5):e0109721. PubMed ID: 34488443
[TBL] [Abstract][Full Text] [Related]
20. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]